Typing single HLA loci for disease associations and drug sensitivity?
Monotype HLA is a suite of Assay and Software combination products for single-locus HLA typing.
-
The assay leverages the power of the Holotype HLA workflow, providing high throughput and high resolution genotyping to facilitate disease association research, population genetics studies and drug sensitivity testing.
- The analysis of high resolution HLA data is supported by HLA Twin, the most accurate genotyping software for the processing of NGS data.
Product Highlights
- Identical protocol for integration with Holotype HLA to maximize flow cell usage
- Amplify only the loci you need for optimal flow cell usage
- Pre-sample indexing up to 576 samples per run ***
- Simple workflow and technician-friendly protocol
- Automated protocol for pre/post PCR
- Whole gene amplification
- Optimized size-selection of fragmented amplicon libraries to help resolve phase and reduce ambiguity
- Indexed adaptors (avoid bias from 2nd PCR step)
- Multiple safe stopping points
- Fully phased whole gene consensus squences
- Customizable kit configuration
- Flexible sequencing strategy to support pooling of different libraries
- Kit splitting and flexibility
- Elimination of error-prone pipetting steps
All timings are for 192 samples, Monotype HLA v3.0
* Timings are based on the Biomek 4000 by Beckman Coulter
** On a MiSeq 300-cycle Micro flow cell
*** Lead time for >192 barcodes varies. Consult your local sales representative for an accurate estimated delivery
What is included in the kit?
- Primer Component Box for 24 or 96 samples
- Library Preparation Reagents Component Box for 24 or 96 samples
- 96 Well Adaptor Plate
- NGS Excel Workbook
- HLA Twin - dual algorithm genotyping software
Technical and Equipment Requirements
- MiniSeq, MiSeq or NextSeq
- Thermal Cycler
- Plate fluorometer or qPCR instrument
- 64-bit computer with a minimum of 16 GB RAM
- Library Size Selection: Pippin Prep or Magnetic Beads
HLA Disease Associations*
- Ankylosing spondylitis ( A24)
- Diabetes, type I (A1, A24)
- Hematochromatosis (A3)
- Myasthenia gravis (A4, A24, A30)
- T-cell adult Leukemia (A26, A28)
- Multiple Sclerosis (A3)
- Papilloma virus susept (A11)
- Spontaneous abortion (A2)
- Stevens–Johnson syndrome (HLA-B*1502)
- HIV (B27, B35, B57)
- Crohn's disease (B27)
- Ulcerative colitis (B27)
- Ankylosing spondylitis (B27)
- Chronic lymphocytic leukemia(HLA-C*16)
- Multinodular goiters(Cw1)
- Anemia (DR5,DR15)
- Aneurysm (DR16)
- Arteritis (DR16)
- Arthritis (DR1, DR4, DR5, DR8, DR12)
- Cardiomyopathy (DR4)
- Colitis (DR1)
- Diabetes (type 1 - DR3, type 2 - DR8)
- Encephalomyelitis (DR17)
- Encephalopathy (DR52)
- Epilepsy (DR5, DR17)
- Heart disease (DR16)
- Hepatitis (DR2, DR11)
- Lupus (DR3, DR4, DR15)
- Lymphadenopathy (DR5)
- Myasthenia (DR1, DR3)
- Myositis (DR17)
- Nephritis(DR1)
- Nephropathy(DR4)
- Pemphigus(DR1, DR4)
- Psoriasis (DR1)
- Papillomatosis (DR1)
- Sarcoidosis (DR17)
- Sclerosis (DR2, DR3, DR3, DR4, DR12)
- Schizophrenia (DR1)
- Susceptibility (DR2, DR3, DR5, DR8, DR10, DR11)
- Thyroiditis (DR3)
- Uveitis (DR1)
- Multiple sclerosis (DRB3*02:02)
- Graves disease (DRB3*01:01)
- Childhood ALL (DRB4*01)
- Lupus (DRB5*01:01)
- Scleroderoma (DRB5*01:05)
- Diabetes (type-1 DPA1*01:03)
- Ankylosing Spondylitis (DPA1*01:03)
- Rheumatoid arthritis ( DPB1*05:10 )
- Graves disease ( DPB1*05:01)
- Multiple sclerosis (DPB1*05:01)
- Diabetes (DQB1*02:01, DQB1*03:02)
- Celiac disease ( DQB1*02:01, DQB1*02:02, DQB1 *03:02)
- Narcolepsy (DQB1*06:02)
- Multiple sclerosis (DQB1*06:02)
- Celiac disease(DQA1*05:01)
- Myasthenia gravis (DQA1*01:01, DQA1*01:02)
- Podoniosis (DQA1*02:01)
- Eosinophilia-myalgia syndrome (DQA1*06:01)
- Achalasia(DQA1*01:03)
*Disclaimer: This list is not complete. There are a lot of new discoveries and the list will be updated regularly.
All Omixon products are available as RUO and certain configurations of Holotype HLA are available as CE-IVD in Europe where marked.